Rheumatology, the journal of the British Society for Rheumatology, is offering free access (through December 31) to its ten most highly cited papers of 2017 and 2018. In this slideshow, we highlight the 10 most cited articles.
ACR has released the results of a new patient survey that shows one in four patients live with rheumatic disease and although most have health insurance, they still have substantial out of pocket costs. The survey shows that many patents have difficulty getting prescribed medications due to step therapy, a controversial health insurance program that requires patients to use the most cost-effective drug therapy instead of the therapy recommended by their physician.
Patients with rheumatoid arthritis often experience flares when symptoms and functionality worsen. Predicting flares and preventing them is a key area of research in rheumatoid arthrits (RA). In this quiz, test how familiar you are with recent findings in this area.
From transitioning a pediatric rheumatology patient to adult care to re-evaluating a missed diagnosis, in this slideshow, we highlight some key presentations from the annual Rheumatology Nurses Society meeting held last month.
Psoriatic arthritis can appear in a variety of ways from nail disease to peripheral joint pain. But, there are a few hallmark signs that can send a rheumatologist or rheumatology nurse in the right direction. In this Q&A, Linda Grinnell-Merrick, NP, discusses the ins and outs of a psoriatic arthritis diagnosis.
In this installment of the psoriatic arthritis quiz, we focus on nail pitting and onycholysis. How familiar are you with the characteristics associated with these two conditions?
Controlling drug costs, optimal infliximab dosage, new treatment guidelines and more in today's rheumatology news update
In today's news roundup from Rheumatology Network, we highlight the week's most popular stories.
Updated treatment recommendations have been issued for ankylosing spondylitis and non-radiographic axial spondyloarthritis. There are 86 recommendations. In this slideshow, we highlight those categorized as "strongly recommended."
In this installment of our monthly rheumatoid arthritis quiz, we focus comorbidities associated with rheumatoid arthritis, adverse drug reactions and the best place to get care in the country. Learn more in this quiz.
In this week's rheumatology news roundup, we feature a Q&A with Dr. Aryeh M. Abeles who talks with Rheumatology Network about his concerns with the black box warning label for the gout treatment febuxostat. We also include a story on addressing prescription abdandonment in rheumatoloyg. These and other stories in today's news roundup.